Performance evaluation of BD Phoenix™, an automated microbiology system, for the screening of IMP-producing Enterobacteriaceae.

[1]  Clinical,et al.  Performance standards for antimicrobial susceptibility testing , 2019 .

[2]  K. Yanagihara,et al.  Performance evaluation of the Verigene®Clostridium difficile nucleic acid test, an automated multiplex molecular testing system for detection of C. difficile toxin. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[3]  B. Limbago,et al.  The Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection , 2016, Journal of Clinical Microbiology.

[4]  Samir N. Patel,et al.  Detection of carbapenemase activity in Enterobacteriaceae: comparison of the carbapenem inactivation method versus the Carba NP test. , 2016, The Journal of antimicrobial chemotherapy.

[5]  S. Essack,et al.  Review of established and innovative detection methods for carbapenemase‐producing Gram‐negative bacteria , 2015, Journal of applied microbiology.

[6]  D. Paterson,et al.  Carbapenemase-producing Enterobacteriaceae. , 2015, Seminars in respiratory and critical care medicine.

[7]  F. Cristini,et al.  Klebsiella pneumoniae Bloodstream Infection , 2014, Medicine.

[8]  T. Kirikae,et al.  Dissemination in Japan of multidrug-resistant Pseudomonas aeruginosa isolates producing IMP-type metallo-β-lactamases and AAC(6')-Iae/AAC(6')-Ib. , 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[9]  I. Balakrishnan,et al.  Comparison of the Phoenix automated system, the Etest method and broth microdilution in determining temocillin susceptibility of Enterobacteriaceae. , 2013, The Journal of antimicrobial chemotherapy.

[10]  G. Daikos,et al.  Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective , 2012, Expert review of anti-infective therapy.

[11]  G. Daikos,et al.  Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions , 2012, Clinical Microbiology Reviews.

[12]  G. Daikos,et al.  Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  P. Nordmann,et al.  Multiplex PCR for detection of acquired carbapenemase genes. , 2011, Diagnostic microbiology and infectious disease.

[14]  W. Dunne,et al.  Detection of Klebsiella pneumoniae Carbapenemase (KPC) Production in Non-Klebsiella pneumoniae Enterobacteriaceae Isolates by Use of the Phoenix, Vitek 2, and Disk Diffusion Methods , 2011, Journal of Clinical Microbiology.

[15]  Neil Woodford,et al.  Comparison of BD Phoenix, Vitek 2, and MicroScan Automated Systems for Detection and Inference of Mechanisms Responsible for Carbapenem Resistance in Enterobacteriaceae , 2010, Journal of Clinical Microbiology.

[16]  Yasuaki Yamada,et al.  Genetic diagnosis of community-acquired MRSA: a multiplex real-time PCR method for Staphylococcal cassette chromosome mec typing and detecting toxin genes. , 2010, The Tohoku journal of experimental medicine.

[17]  J. W. Snyder,et al.  Direct Comparison of the BD Phoenix System with the MicroScan WalkAway System for Identification and Antimicrobial Susceptibility Testing of Enterobacteriaceae and Nonfermentative Gram-Negative Organisms , 2008, Journal of Clinical Microbiology.

[18]  Y. Ishii,et al.  Nosocomial outbreak of genetically related IMP-1 beta-lactamase-producing Klebsiella pneumoniae in a general hospital in Japan. , 2007, International journal of antimicrobial agents.

[19]  Karen C. Carroll,et al.  Evaluation of the BD Phoenix Automated Microbiology System for Identification and Antimicrobial Susceptibility Testing of Enterobacteriaceae , 2006, Journal of Clinical Microbiology.

[20]  N. Woodford,et al.  Carbapenemases: a problem in waiting? , 2000, Current opinion in microbiology.